How to Establish a High-risk Cancer Genetics Clinic: Limitations and Successes

Overview

Journal Curr Oncol Rep

Publisher Current Science

Specialty Oncology

Date 2005 Oct 14

PMID 16221384

Citations 3

Authors

Mary B Daly

Beth Stearman

Agnes Masny

Elaine Sein

Susan Mazzoni

Affiliations

Soon will be listed here.

Abstract

The development of technology to locate and isolate cancer susceptibility genes has brought together the fields of oncology, cancer control, genetics, and genetic counseling to create a new specialty of cancer risk counseling with the goal to communicate more accurate information about personal cancer risk profiles based on personal and family histories. As cancer risk assessment and counseling services become standard of care in medical practice, their availability is increasingly moving from comprehensive cancer centers and academic institutions to community settings. High-risk cancer genetics clinics in the community face several challenges, including staffing, time commitment, costs, and unique quality control issues. The societal benefits include a more educated public armed with the information needed to make health decisions appropriate for the individual level of risk.

Citing Articles

The Community Oncology and Academic Medical Center Alliance in the Age of Precision Medicine: Cancer Genetics and Genomics Considerations.

Melas M, Subbiah S, Saadat S, Rajurkar S, McDonnell K J Clin Med. 2020; 9(7).

PMID: 32640668 PMC: 7408957. DOI: 10.3390/jcm9072125.

Patient and provider perspectives on adherence to and care coordination of lynch syndrome surveillance recommendations: findings from qualitative interviews.

Schneider J, Goddard K, Muessig K, Davis J, Rope A, Hunter J Hered Cancer Clin Pract. 2018; 16:11.

PMID: 29760830 PMC: 5946437. DOI: 10.1186/s13053-018-0090-4.

Development and validation of a simple questionnaire for the identification of hereditary breast cancer in primary care.

Ashton-Prolla P, Giacomazzi J, Schmidt A, Roth F, Palmero E, Kalakun L BMC Cancer. 2009; 9:283.

PMID: 19682358 PMC: 2739222. DOI: 10.1186/1471-2407-9-283.

References

Wideroff L, Vadaparampil S, Greene M, Taplin S, Olson L, Freedman A . Hereditary breast/ovarian and colorectal cancer genetics knowledge in a national sample of US physicians. J Med Genet. 2005; 42(10):749-55. PMC: 1735923. DOI: 10.1136/jmg.2004.030296. View

Green M, Botkin J . "Genetic exceptionalism" in medicine: clarifying the differences between genetic and nongenetic tests. Ann Intern Med. 2003; 138(7):571-5. DOI: 10.7326/0003-4819-138-7-200304010-00013. View

Baty B, Venne V, McDonald J, Croyle R, Halls C, Nash J . BRCA1 Testing: Genetic Counseling Protocol Development and Counseling Issues. J Genet Couns. 2015; 6(2):223-44. DOI: 10.1023/A:1025620404473. View

Fraser L, Bramald S, Chapman C, Chu C, Cornelius V, Douglas F . What motivates interest in attending a familial cancer genetics clinic?. Fam Cancer. 2004; 2(3-4):159-68. DOI: 10.1023/b:fame.0000004621.38109.16. View

Sweet K, Bradley T, Westman J . Identification and referral of families at high risk for cancer susceptibility. J Clin Oncol. 2002; 20(2):528-37. DOI: 10.1200/JCO.2002.20.2.528. View

Lawrence W, Peshkin B, Liang W, Isaacs C, Lerman C, Mandelblatt J . Cost of genetic counseling and testing for BRCA1 and BRCA2 breast cancer susceptibility mutations. Cancer Epidemiol Biomarkers Prev. 2001; 10(5):475-81. View

Green M, Peterson S, Baker M, Harper G, Friedman L, Rubinstein W . Effect of a computer-based decision aid on knowledge, perceptions, and intentions about genetic testing for breast cancer susceptibility: a randomized controlled trial. JAMA. 2004; 292(4):442-52. PMC: 1237120. DOI: 10.1001/jama.292.4.442. View

Moller P . Costs and benefits of diagnosing familial breast cancer. Ann Oncol. 2004; 15 Suppl 1:I55-I59. DOI: 10.1093/annonc/mdh659. View

Armstrong K, Weber B, Ubel P, Guerra C, Schwartz J . Interest in BRCA1/2 testing in a primary care population. Prev Med. 2002; 34(6):590-5. DOI: 10.1006/pmed.2002.1022. View

10.

Hofman K, Tambor E, Chase G, Geller G, Faden R, Holtzman N . Physicians' knowledge of genetics and genetic tests. Acad Med. 1993; 68(8):625-32. DOI: 10.1097/00001888-199308000-00013. View

11.

Griffith G, Tudor-Edwards R, Gray J, Butler R, Wilkinson C, Turner J . A micro costing of NHS cancer genetic services. Br J Cancer. 2004; 92(1):60-71. PMC: 2361743. DOI: 10.1038/sj.bjc.6602270. View

12.

Carmona R, Wattendorf D . Personalizing prevention: the U.S. Surgeon General's Family History Initiative. Am Fam Physician. 2005; 71(1):36, 39. View

13.

Costalas J, Itzen M, Malick J, Babb J, Bove B, Godwin A . Communication of BRCA1 and BRCA2 results to at-risk relatives: a cancer risk assessment program's experience. Am J Med Genet C Semin Med Genet. 2003; 119C(1):11-8. DOI: 10.1002/ajmg.c.10003. View

14.

Lim J, Macluran M, Price M, Bennett B, Butow P . Short- and long-term impact of receiving genetic mutation results in women at increased risk for hereditary breast cancer. J Genet Couns. 2004; 13(2):115-33. DOI: 10.1023/b:jogc.0000018822.56297.a6. View

15.

Freedman A, Wideroff L, Olson L, Davis W, Klabunde C, Srinath K . US physicians' attitudes toward genetic testing for cancer susceptibility. Am J Med Genet A. 2003; 120A(1):63-71. DOI: 10.1002/ajmg.a.10192. View

16.

Wilson B, Torrance N, Mollison J, Wordsworth S, Gray J, Haites N . Improving the referral process for familial breast cancer genetic counselling: findings of three randomised controlled trials of two interventions. Health Technol Assess. 2005; 9(3):iii-iv, 1-126. DOI: 10.3310/hta9030. View

17.

Surh L, Wright P, Cappelli M, Kasaboski A, Hastings V, Hunter A . Delivery of molecular genetic services within a health care system: time analysis of the clinical workload. The Molecular Genetic Study Group. Am J Hum Genet. 1995; 56(3):760-8. PMC: 1801167. View

18.

Baty B, Kinney A, Ellis S . Developing culturally sensitive cancer genetics communication aids for African Americans. Am J Med Genet A. 2003; 118A(2):146-55. DOI: 10.1002/ajmg.a.10150. View

19.

Thompson H, Valdimarsdottir H, Jandorf L, Redd W . Perceived disadvantages and concerns about abuses of genetic testing for cancer risk: differences across African American, Latina and Caucasian women. Patient Educ Couns. 2003; 51(3):217-27. DOI: 10.1016/s0738-3991(02)00219-7. View

20.

Augustine K, Bogan T . Operating a comprehensive high-risk breast cancer management program in a community hospital setting. AWHONN Lifelines. 2004; 8(5):434-40. DOI: 10.1177/1091592304271626. View